Soluble Fas is a marker of peripheral arterial occlusive disease in haemodialysis patients

Nephrology Dialysis Transplantation

Volumn 17, Issue 3, 2002, Pages 485-491

  Masse, Mélanie ^a   Hébert, Marie Josée ^b   Troyanov, Stéphan ^c   Vigneault, Normand ^b   Sirois, Isabelle ^c   Madore, François ^c  

^a CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

Author keywords

Apoptosis; Atherosclerosis; Haemodialysis; Inflammation; Peripheral arterial occlusive disease; sFas

Indexed keywords

ACETYLSALICYLIC ACID; C REACTIVE PROTEIN; FAS ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; CIGARETTE SMOKING; COHORT ANALYSIS; CONTROLLED STUDY; DATA ANALYSIS; DIABETES MELLITUS; DISEASE MARKER; FEMALE; HEMODIALYSIS PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN FUNCTION; RISK FACTOR; SOLUBILITY;

EID: 0036198451     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/17.3.485     Document Type: Article

References (21)

1. Annual report on management of renal failure in Europe
2. Cardiac and cerebrovascular disease in chronic uremia
3. Atherosclerosis-an inflammatory disease
4. Changing concepts of atherogenesis
5. Apoptosis in human atherosclerosis and restenosis
6. Apoptosis in the atherosclerotic plaque: Quantitative and qualitative aspects
7. Expression of Fas ligand in arteries of hypercholesterolemic rabbits accelerates atherosclerotic lesion formation
8. Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability
9. Fas is expressed in human atherosclerotic intima and promotes apoptosis of cytokine-primed human vascular smooth muscle cells
10. The role of Fas/APO 1 and apoptosis in the development of human atherosclerotic lesions
11. FAS and FAS ligand: A death factor and its receptor
12. Soluble Fas/APO-1 splicing variants and apoptosis
13. Clinical implications of circulating soluble FAS and FAS-ligand in patients with acute myocardial infarction
14. Markers of apoptosis and inflammation are predictive of cardiovascular disease in hemodialysis patients
15. Soluble Fas is a marker of coronary artery disease in patients with end-stage renal disease
16. Lower-extremity arteriosclerosis as a reflection of a systemic process: Implications for concomitant coronary and carotid disease
17. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients
18. Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure
19. Fas-Fas ligand system in the peripheral blood of patients with renal diseases
20. Discrepant expression of membrane and soluble isoforms of Fas (CD95/APO-1) in adult T-cell leukaemia: Soluble Fas isoform is an independent risk factor for prognosis